Rosen Law Firm Investigates Potential Securities Claims Against GeneDx Holdings Corp.
On June 23, 2025, the Rosen Law Firm, a prominent global investor rights law firm, declared an investigation into GeneDx Holdings Corp. (NASDAQ: WGS). This investigation comes in light of serious allegations that GeneDx may have provided the investing public with significantly misleading business information, potentially violating securities laws.
The impetus for this inquiry stems from a deeply critical report published by Grizzly Research on February 5, 2025. The report, titled "Insiders Attest that GeneDx (NASDAQ: WGS) Is Actively Committing Widespread Fraud," raised concerns about the integrity of GeneDx's business practices. According to the report, the firm's growth was characterized as a facade, allegedly bolstered by fraudulent tactics targeting Medicare and Medicaid systems to unjustly increase reported revenues. Following the release of this damaging report, GeneDx’s stock experienced a sharp decline, plummeting 6.7% in a single day.
Rosen Law Firm urges investors who purchased GeneDx securities to consider this potential class action as a means of recovering any losses incurred as a result of these allegations. Investors may qualify for compensation through a contingency fee arrangement—meaning they won't have to pay any out-of-pocket costs.
To join the class action, affected investors can easily submit a form through the Rosen Law Firm’s dedicated webpage at rosenlegal.com, or they can contact Phillip Kim, Esq., toll-free at 866-767-3653 for further assistance.
This investigation highlights the importance of seeking experienced legal representation in cases involving securities class actions. The Rosen Law Firm differentiates itself by boasting a history of successful outcomes in similar cases. Many firms that send out notices may not possess comparable experience or recognition, making it crucial for investors to choose counsel wisely. The firm specializes in securities class action litigation, having previously achieved the largest securities settlement against a Chinese firm at one point in history. Ranking as the number one firm by ISS Securities Class Action Services for securities settlements in 2017, Rosen Law Firm has consistently maintained a top-four rank since 2013 and has recovered hundreds of millions for investors, including a remarkable $438 million secured in 2019 alone. The firm’s founding partner, Laurence Rosen, was honored as a Titan of the Plaintiffs' Bar by Law360 for his notable contributions.
The Rosen Law Firm remains committed to who support individuals in navigating the complexities of securities law. Their experience and dedication to achieving justice for investors set them apart in this competitive field.
For further updates, potential investors and interested parties can follow the Rosen Law Firm on their social media channels including LinkedIn, Twitter, and Facebook, ensuring they're kept informed about the latest developments in their cases and other securities actions.
Attorney advertising is common in these situations, as past results do not guarantee similar outcomes in future cases. Therefore, staying informed and taking proactive steps in light of these allegations against GeneDx can be instrumental in the quest for justice and recovery of losses.
The impetus for this inquiry stems from a deeply critical report published by Grizzly Research on February 5, 2025. The report, titled "Insiders Attest that GeneDx (NASDAQ: WGS) Is Actively Committing Widespread Fraud," raised concerns about the integrity of GeneDx's business practices. According to the report, the firm's growth was characterized as a facade, allegedly bolstered by fraudulent tactics targeting Medicare and Medicaid systems to unjustly increase reported revenues. Following the release of this damaging report, GeneDx’s stock experienced a sharp decline, plummeting 6.7% in a single day.
Rosen Law Firm urges investors who purchased GeneDx securities to consider this potential class action as a means of recovering any losses incurred as a result of these allegations. Investors may qualify for compensation through a contingency fee arrangement—meaning they won't have to pay any out-of-pocket costs.
To join the class action, affected investors can easily submit a form through the Rosen Law Firm’s dedicated webpage at rosenlegal.com, or they can contact Phillip Kim, Esq., toll-free at 866-767-3653 for further assistance.
This investigation highlights the importance of seeking experienced legal representation in cases involving securities class actions. The Rosen Law Firm differentiates itself by boasting a history of successful outcomes in similar cases. Many firms that send out notices may not possess comparable experience or recognition, making it crucial for investors to choose counsel wisely. The firm specializes in securities class action litigation, having previously achieved the largest securities settlement against a Chinese firm at one point in history. Ranking as the number one firm by ISS Securities Class Action Services for securities settlements in 2017, Rosen Law Firm has consistently maintained a top-four rank since 2013 and has recovered hundreds of millions for investors, including a remarkable $438 million secured in 2019 alone. The firm’s founding partner, Laurence Rosen, was honored as a Titan of the Plaintiffs' Bar by Law360 for his notable contributions.
The Rosen Law Firm remains committed to who support individuals in navigating the complexities of securities law. Their experience and dedication to achieving justice for investors set them apart in this competitive field.
For further updates, potential investors and interested parties can follow the Rosen Law Firm on their social media channels including LinkedIn, Twitter, and Facebook, ensuring they're kept informed about the latest developments in their cases and other securities actions.
Attorney advertising is common in these situations, as past results do not guarantee similar outcomes in future cases. Therefore, staying informed and taking proactive steps in light of these allegations against GeneDx can be instrumental in the quest for justice and recovery of losses.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.